neutropenia | CMAC

neutropenia

Review of the ASCO and IDSA clinical practice guidelines on antimicrobial prophylaxis for adult patients with cancer-related immunosupression

Patients undergoing cytotoxic chemotherapy and hematopoietic stem-cell transplantation are at risk for infection. The risk of infections increases with the depth and duration of neutropenia, with the greatest risk occurring in patients who experience …

Empirical, Pre-emptive and Prophylactic Therapy of Invasive Mycoses: Current State of the Problem

Invasive mycoses in patients with severe diseases – ICU patients, patients with hematological malignancies and after solid organ transplantations represent a significant target for the use of prophylactic, empirical and pre-emptive antifungal …

Practice Guidelines for the Antimicrobial Therapy in Neutropenic Patients with Cancer (According to the Guidelines of Infections Diseases Society of America)

Febrile neutropenia is becoming significant problem in Russian medical institutions. Changes in spectrum of causative pathogens, increase of the number of neutropenic patients and emergence of antimicrobial resistance – all the above factors require …

Efficacy of Cefepime Monotherapy and The Combination of Ceftazidime with an Aminoglycoside in The Treatment of Infections in Oncology Patients with Severe Neutropenia

The combination of ceftazidime with an aminoglycoside is a commonly used standard for empiric therapy of febrile neutropenia. A lot of attention is paid to the development of effective monotherapy for the treatment of this condition. One of the most …